AIxCrypto and BitMart Launch Co‑Branded Virtual Prepaid Card for Web3 Payments
- AIxCrypto partners with BitMart to launch a co‑branded virtual prepaid card bringing Web3 to everyday digital payments for its community. • AIxCrypto keeps a non‑regulated role: community reach, brand participation and marketing; it doesn't handle issuance or payment settlement. • AIxCrypto highlights BesTrade DeAI Agent and a roadmap integrating AI and blockchain, framing the card as real‑world payments utility.
Co‑branded Virtual Prepaid Card Links Web3 to Everyday Commerce
AIxCrypto announces a strategic partnership with BitMart to launch a co‑branded virtual prepaid card aimed at bringing Web3 capabilities into routine digital payments. The card is designed for everyday online spending and integration with major digital wallet ecosystems, and is available to eligible users subject to applicable terms and regional availability. AIxCrypto positions the product as a practical utility to expand crypto and blockchain use beyond trading and into everyday commerce for its global community.
The agreement deliberately separates roles between the two firms to create a compliant operating model. BitMart acts as the exclusive operator of the card program and assumes responsibility for card issuance, user onboarding, compliance, customer support and all payment infrastructure, including adherence to regulatory, licensing and network requirements. AIxCrypto contributes community reach, brand participation and marketing channels, keeping its role focused on ecosystem engagement rather than regulated financial operations.
The collaboration underscores AIxCrypto’s strategic emphasis on scalability and regulatory clarity as it seeks to bridge Web2 and Web3 experiences. The card supports major digital wallet networks and merchants that accept prepaid cards, while specifics such as rollout timing, eligibility criteria, transaction limits, fees and supported currencies are disclosed by BitMart in line with regional laws, licensing timelines and payment network rules. The announcement contains customary forward‑looking language noting that expected actions and results are subject to risks and uncertainties.
Operational and Compliance Boundaries
BitMart bears sole responsibility for the regulated elements of the program, including obtaining any required licenses and meeting consumer protection standards in each jurisdiction where the card becomes available. AIxCrypto’s role is explicitly non‑regulated, focusing on marketing, community channels and product participation to drive adoption without handling issuance or payment settlement.
Product Roadmap and Ecosystem Focus
AIxCrypto highlights its BesTrade DeAI Agent and other AIxC ecosystem products as part of a broader roadmap to integrate artificial intelligence and blockchain. The company frames the card partnership as a step toward real‑world utility for digital asset users, aligning payments functionality with its longer‑term goal of connecting AI services and blockchain infrastructure.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…